Delivery Order SPE2DR25D1053-SPE2DR26FV228
Award Date 1/5/26
Potential Completion Date 1/27/26
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $32,737.77 to AmerisourceBergen Drug Corp for the supply of Ultomiris 300 mg/3 ml vials on November 12, 2025. This competitive award utilizes firm fixed pricing with an ultimate completion date of December 4, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $52,571.70 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Ultomiris 1,100 mg/11 ml vials. This firm fixed-price, competitively awarded contract is scheduled for completion by October 15, 2025, with performance occurring at the vendor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $9,558.52 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ultomiris 300 mg/3 ml vials. This non-competitive delivery order, with an ultimate completion date of September 29, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,285.85 to AmerisourceBergen Drug Corp for the supply of Ultomiris 1,100 mg/11 ml vials. This firm fixed-price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of September 16, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger indefinite delivery contract (IDC) vehicle....
- The Defense Logistics Agency awarded a delivery order valued at $32,737.85 to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegcetacoplan) 1,100 mg/11 ml vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, to be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025. The delivery order was issued on November 10, 2025, as part of the company's broader federal medical...
- The Defense Logistics Agency awarded a $20,146.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ultomiris (pegcetacoplan) 300 mg/3 mL vials on November 13, 2025, with an ultimate completion date of December 5, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The pharmaceutical...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $102,754.09 for Ultomiris 300 mg/3 mL vials on September 15, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is scheduled for...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ultomiris (pegtibatimab alfa), a specialty pharmaceutical product, with a ceiling value of $26,285.85. This firm fixed-price delivery order is set to be completed by August 14, 2025, and represents performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $87,619.50 to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegcetacoplan) 1,100 mg/11 mL vials. This contract is a firm fixed price delivery order with no set-aside designation, issued competitively on June 11, 2025, with an ultimate completion date of July 3, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $9,233.75 to AmerisourceBergen Drug Corp for the supply of Ultomiris (pegcetacoplan) 1,100 mg/11 ml vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 5, 2025. The award was made on November 13, 2025, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...